Growth and development until 18 months of children exposed to tocolytics indomethacin or nylidrin.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Neuropediatrics

• Publication date

  1996-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1055/S-2007-973782PMID 8892364
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Increased incidence of bronchopulmonary dysplasia after antenatal administration of indomethacin to prevent preterm labor.

  1994cited by this paper
• Tocolysis with indomethacin increases the incidence of necrotizing enterocolitis in the low-birth-weight neonate.

  1994cited by this paper
• Neonatal complications after the administration of indomethacin for preterm labor

  1993cited by this paper
• Regional cerebral blood flow velocity changes after indomethacin infusion in preterm infants.

  1992cited by this paper
• Neonatal periventricular-intraventricular hemorrhage after maternal beta-sympathomimetic tocolysis. The March of Dimes Multicenter Study Group.

  1992cited by this paper
• The Effect of Intrauterine Alcohol Exposition in Various Durations on Early Cognitive Development

  1991cited by this paper
• A Randomized Double-Dummy Comparison Between Indomethacin and Nylidrin in Threatened Preterm Labor

  1991cited by this paper
• CEREBRAL LESIONS IN PRETERM INFANTS AFTER TOCOLYTIC INDOMETHACIN

  1990cited by this paper
• Safety and Efficacy of Long-Term Tocolysis with Indomethacin

  1990cited by this paper
• Efficacy and safety of indomethacin versus ritodrine in the management of preterm labor; A randomized study

  1989cited by this paper
• A Novel Format for a Growth Chart

  1984cited by this paper
• B-mode echoencephalography in the normal and high risk infant.

  1979cited by this paper

• Prenatal exposure to non‐steroidal anti‐inflammatory drugs and risk of attention‐deficit/hyperactivity disorder: A follow‐up study in the Norwegian mother, father and child cohort

  2021cites this paper
• Use and validity of child neurodevelopment outcome measures in studies on prenatal exposure to psychotropic and analgesic medications – A systematic review

  2019cites this paper
• Drugs for the Treatment and Prevention of Preterm Labor.

  2019cites this paper
• Atosiban – A Specific Evolution for the Management of Preterm Labour

  2017cites this paper
• Cyclo-oxygenase (COX) inhibitors for treating preterm labour.

  2015cites this paper
• Use of non-steroidal anti-inflammatory drugs in pregnancy: impact on the fetus and newborn.

  2012cites this paper
• Indomethacin Tocolysis and Neurodevelopmental Outcome

  2011cites this paper
• Neurodevelopmental outcome of premature infants after exposure to antenatal indomethacin.

  2008cites this paper
• Metaanalysis of the effect of antenatal indomethacin on neonatal outcomes.

  2007cites this paper
• Assessing the Neonatal Safety of Indomethacin Tocolysis: A Systematic Review With Meta-Analysis

  2005cites this paper
• Cyclo-oxygenase (COX) inhibitors for treating preterm labour.

  2005cites this paper
• Cyclo-oxygenase (COX) inhibitors for treating preterm labour (Review)

  2005cites this paper
• Efficacy and specificity of non-steroidal anti-inflammatory drugs for the inhibition of cytokine-stimulated prostaglandin E(2) secretion by amnion-derived WISH cells.

  2002cites this paper
• Effects of perinatal indomethacin treatment on preterm infants

  2000cites this paper
• Neurodevelopment until the adjusted age of 2 years in extremely low birth weight infants after early intervention--a case-control study.

  1998cites this paper